S. 1182 · 118th Congress (2023–2025)
340B Reporting and Accountability Act
This bill requires providers participating in the 340B drug discount program to ensure patients receive covered outpatient drugs at a price that does not exceed the amount the provider paid, minus any additional discounts or rebates the provider receives.
Further, participating providers must report annually information about amounts paid and received for covered outpatient drugs and how any excess revenue was spent.
Show official title
A bill to amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 1182’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. John Kennedy (R-LA)
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
340B Reporting and Accountability Act
Display title, Short title · Introduced in Senate
A bill to amend the Public Health Service Act to increase the transparency and accountability of the drug discount program, and for other purposes.
Official title · Introduced in Senate